Image

Vision on the Road: Vision Rehabilitation for Driving After Stroke

Vision on the Road: Vision Rehabilitation for Driving After Stroke

Recruiting
20-85 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to learn if vision training works to improve functional vision in people with visual field loss after stroke. The investigators want to know more about how people perceive their own functional vision and ability to compensate for visual field loss in daily activities.

The main questions the study aims to answer are:

  • Does vision training improve dimensions of functional vision?
  • How does vision training affect the participants's perception of functional vision and the ability to compensate for visual field loss? Researchers will compare the effect of home-based vision training to standard care (no vision training) on functional vision.

Participants will:

  • Participate in home-based vision training or standard care for 8 weeks
  • Be contacted once a week by phone
  • Keep a training diary

Description

AIM

The overall aim is to obtain knowledge about the effects of compensatory visual rehabilitation strategies on functional vision in people with stroke who do not meet the health prerequisites for visual field, as defined in the Driving licences regulations in Norway. Specifically, to describe the effect on functional vision and the compensatory vision strategies related to traffic situations. Secondary, to explore markers for perceived functional vision and functional visual field that may predict an effect of visual rehabilitation.

DESIGN

The study will be performed as an open, controlled and randomized trial with semi-cross-over design. The participants will be allocated to an immediate- or delayed intervention following a pre-randomized list. The participants are allocated to immediate intervention (Fast track; Group A) will be investigated at baseline, after 8 and 20 weeks. The remaining participant are allocated to delayed intervention (Delayed start; Group B) will start the intervention 8 weeks after the baseline and investigated at baseline, week 8, week 20 and week 28.

SETTING /RECRUITMENT The study sample will consist of adults with post-stroke visual field defects. All the three sub-studies will have the same study sample.

Eligibility

Inclusion criteria:

  • Adults aged 20-85 years with a visual field defect following stroke
  • Norwegian Class 1 driving licence revoked no more than five years ago
  • Speak a Scandinavian language
  • Able to provide written informed consent
  • Motivated and willing to participate in study activities for a total of 20 to 28 weeks
  • Own a personal computer (for digital follow-up and online vision training)
  • Able to travel to Oslo for data collection

Exclusion criteria:

  • Presence of strabismus and/or visual neglect
  • Eye disease or other health conditions that do not meet the health requirements for a Norwegian Class 1 driver's license
  • Cognitive impairment, dementia, severe psychiatric diagnosis, or inability to provide written informed consent

Study details
    Stroke
    Visual Field Loss
    Hemianopia

NCT07147660

University of South-Eastern Norway

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.